NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
21/01/2021
Voltar para busca
Dado oficial do USPTO
CCPLUS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
58
Atualização mais recente
21/01/2021
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 10
Data de depósito
19/06/2007
Data de registro
18/01/2011
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
21/01/2021
Última transação
21/01/2021
Escritório responsável
United States Patent and Trademark Office
Código da situação
800
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
24
Localização do titular
MALMO, SE
Examinador
FALK, ERIN
Unidade examinadora
L10
Localização atual
GENERIC WEB UPDATE
Titulares e representantes
Titulares
SVAR LIFE SCIENCE AB
Euro-Diagnostica AB
Representantes
Kevin A. Thompson LADAS & PARRY LLP
Classificação técnica
Classes Nice
Classe 5Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Diagnostic preparations for clinical or medical laboratory use; medical diagnostic reagents and assays for testing of bodily fluids; medical diagnostic reagents; diagnostic agentspreparations and substances for medical purposes; kits comprised principally of medical diagnostic assays for testing of bodily fluids; testing kits containing peptide substrates used in analyzing and detecting certain proteins indicating onset of human joint inflammatory diseasefor clinical or laboratory use; in vitro diagnostic test kits for detection of rheumatoid arthritis comprised primarily of reagents for medical diagnostic use; biomedical compoundspeptide substrates used in analyzing and detecting certain antibodies to cyclic citrullinated peptides for clinical or medical laboratory use; testing kits containing peptide substrates used in analyzing and detecting certain antibodies to cyclic citrullinated peptides for clinical or medical laboratory use; medical diagnostic test kits for the detection of rheumatoid arthritisprincipally comprised of microtitre peptide substrates and reagents; medical diagnostic test kitsfeaturing reagents and peptide coated receptacle substratesfor the detection of auto-immune joint disease; medical diagnostic enzyme linked immunoassay (ELISA) testscomprised primarily of medical diagnostic preparations in the nature of bodily serum(a) holders such as microtitre plates with wells having areas coated with antigenic preparations(s) for detection of antibodies to cyclic citrullinated peptides (CCP)for clinical or laboratory use
Classe 10
Apparatus for clinical diagnosis; apparatus for blood analysis; blood testing apparatus
Publicações
Histórico de despachos e eventos da marca no USPTO.
58 publicações encontradas
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
21/01/2021
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
21/01/2021
E89R
TEAS SECTION 8 & 9 RECEIVED
19/01/2021
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
26/02/2020
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
18/01/2020
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
06/03/2017
C15P
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06/03/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/03/2017
E815
TEAS SECTION 8 & 15 RECEIVED
03/01/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
18/01/2011
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/11/2010
PUBO
PUBLISHED FOR OPPOSITION
02/11/2010
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
27/09/2010
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
24/09/2010
DMCC
DATA MODIFICATION COMPLETED
23/09/2010
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/08/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/08/2010
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
06/08/2010
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
06/08/2010
GNSI
INQUIRY TO SUSPENSION E-MAILED
06/08/2010
CNSI
SUSPENSION INQUIRY WRITTEN
06/08/2010
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
09/07/2010
ALIE
ASSIGNED TO LIE
09/07/2010
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
05/01/2010
GNSL
LETTER OF SUSPENSION E-MAILED
05/01/2010
CNSL
SUSPENSION LETTER WRITTEN
05/01/2010
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/12/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/12/2009
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
07/12/2009
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
16/06/2009
GNSI
INQUIRY TO SUSPENSION E-MAILED
16/06/2009
CNSI
SUSPENSION INQUIRY WRITTEN
16/06/2009
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
26/05/2009
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
26/11/2008
GNSL
LETTER OF SUSPENSION E-MAILED
26/11/2008
CNSL
SUSPENSION LETTER WRITTEN
26/11/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
25/10/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
25/10/2008
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
15/10/2008
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/09/2008
GNRT
NON-FINAL ACTION E-MAILED
10/09/2008
CNRT
NON-FINAL ACTION WRITTEN
10/09/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/08/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/08/2008
ALIE
ASSIGNED TO LIE
02/08/2008
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
31/07/2008
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/02/2008
GNRT
NON-FINAL ACTION E-MAILED
06/02/2008
CNRT
NON-FINAL ACTION WRITTEN
06/02/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
27/12/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
27/12/2007
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
27/12/2007
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/10/2007
GNRT
NON-FINAL ACTION E-MAILED
10/10/2007
CNRT
NON-FINAL ACTION WRITTEN
10/10/2007
DOCK
ASSIGNED TO EXAMINER
21/09/2007
NWAP
NEW APPLICATION ENTERED
22/06/2007
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CCPLUS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.